Third Circuit Confirms Merck’s Win in Whistleblower Action over Mumps Vaccine Effectiveness
- August 09, 2024
The Third Circuit rejected August 6 a whistleblower action under the False Claims Act (FCA) alleging Merck & Co. defrauded the federal government by misrepresenting the effectiveness and shelf life of its mumps vaccine.
ARTICLE TAGS
You must be logged in to access this content.